Copper deficiency neuropathy, idiopathic treated subcutaneously
DOI:
https://doi.org/10.32818/reccmi.a5n1a8Keywords:
myeloneuropathy, copper deficiency.Abstract
Myeloneuropathy associated with acquired copper deficiency is a rare condition that has been detected in several species and, recently, in humans, with much variability in its form of display, and usually with anemia and leukopenia. Cases have been reported on people between 30-82 year-old. Half of the cases are due to secondary malabsorption of the gastric resection surgery, with symptomatology appearing even years later. These symptoms are similar to those caused by vitamin B12 deficit. There are idiopathic cases, like the one we are presenting, where the patient improved both clinically and analytically by administrating subcutaneous copper histidine supplements.
Downloads
Metrics
References
Kumar N. Copper deficiency myeloneuropathy. Post TW, ed. UpToDate. Waltham, MA. UpToDate Inc. https://www.uptodate.com (accessed on September 25, 2019).
Urtiaga S, Terrero R, Malumbres M, Pinel A. Mielopatía por déficit de cobre: la gran simuladora. Neurología. 2018; 33(4): 278-281. https://doi.org/10.1016/j.nrl.2017.02.009.
Schleper B, Stuerenburg HJ. Copper deficiency-associated myelopathy in a 46-year-old woman. J Neurol. 2001; 248(8): 705-706. https://doi.org/10.1007/s004150170118.
Koppel BS. Trastornos neurológicos nutricionales y relacionados con el alcohol. En: Goldman L, Schafer AI. Tratado de Medicina Interna, 25 ed. Barcelona. Elsevier, 2017; 2507-2510.
Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc. 2006; 81(10): 371-384. https://doi.org/10.4065/81.10.1371.
Jaiser SR, Winston GP. Copper deficiency myelopathy. J Neurol. 2010; 257(6): 869-881. https://doi.org/10.1007/s00415-010-5511-x.
Sarkar B, Lingertat-Walsh K, Clarke JT. Copper-histidine therapy for Menkes disease. J Pediatr. 1993; 123(5): 828-830. https://doi.org/10.1016/s0022-3476(05)80870-4.
Kreuder J, Otten A, Fuder H, Tümer Z, Tønnesen T, Horn N, et al. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease. Eur J Pediatr. 1993; 152(10): 828-832. https://doi.org/10.1007/bf02073380.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Joaquín Antón-Martínez, Cristina González-Tena, María del Carmen Pecero-Hormigo, Lara Martín-Rizo, María Inmaculada Rubio-Merino
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
